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###### SYNOPSIS

Our case adds to the severe neonatal presentation of COG6‐CDG with prominent skin manifestations at birth and emphasizes the importance of considering the congenital disorders of glycosylation among the possible causes for congenital syndromic genodermatoses.

1. INTRODUCTION {#jmd212154-sec-0003}
===============

Many of the metabolic diseases leading to death in the perinatal period follow autosomal recessive inheritance and bear specific challenges for genetic counseling and prenatal diagnostics in future pregnancies. Carrier parents are clinically unaffected, and diseases are rare but have recurrence risks of 25% in the same family. Often, affected children die before a genetic diagnosis can be established, precluding targeted carrier testing in parents and prenatal or preimplantation genetic diagnosis in further pregnancies.

Restrictive dermopathy (RD, MIM: \#275210) is a rare, lethal genodermatosis with manifestations easily recognizable at birth: tense, vulnerable and translucent skin, superficial erosions, joint contractures, reduced motoricity and a typical facies with a small pinched nose, mouth fixed in an o‐position, low‐set ears, micrognathia, and respiratory insufficiency.[^1^](#jmd212154-bib-0001){ref-type="ref"} Prenatal signs include intrauterine growth retardation, reduced fetal movements, polyhydramnios, and premature rupture of the amniotic membrane. Most infants show a fatal course and die within the first week of life.[^1^](#jmd212154-bib-0001){ref-type="ref"}, [^2^](#jmd212154-bib-0002){ref-type="ref"}, [^3^](#jmd212154-bib-0003){ref-type="ref"}

Congenital disorders of glycosylation (CDG) are due to defects in the glycosylation of glycoproteins or glycolipids. The clinical phenotype of CDG ranges from mild symptoms to severe multisystem dysfunction and even a fatal course[^4^](#jmd212154-bib-0004){ref-type="ref"} including forms also classified under syndromic ichthyosis.[^5^](#jmd212154-bib-0005){ref-type="ref"}, [^6^](#jmd212154-bib-0006){ref-type="ref"} Seven known CDGs are deficiencies in the conserved oligomeric Golgi (COG) complex (COG1, 2, 4, 5, 6, 7, and 8)[^7^](#jmd212154-bib-0007){ref-type="ref"}, [^8^](#jmd212154-bib-0008){ref-type="ref"}, [^9^](#jmd212154-bib-0009){ref-type="ref"} that controls Golgi trafficking, processing, and sorting.[^10^](#jmd212154-bib-0010){ref-type="ref"} COG6‐CDG (MIM: \#614576) is caused by deficiency of subunit 6 of COG, and is characterized by growth retardation, global developmental delay, muscular hypotonia, microcephaly, liver and gastrointestinal disease, thrombocytopenia, recurrent infections, episodic fever, congenital heart defects, generalized joint contractures, and early lethality.[^11^](#jmd212154-bib-0011){ref-type="ref"}, [^12^](#jmd212154-bib-0012){ref-type="ref"}, [^13^](#jmd212154-bib-0013){ref-type="ref"}, [^14^](#jmd212154-bib-0014){ref-type="ref"} It has been proposed that a distinctive feature of COG6‐CDG compared to other CDG can be additional ectodermal signs comprising hypohidrosis/hyperthermia, thickened skin, hyperkeratosis, dry skin, and tooth anomalies.[^11^](#jmd212154-bib-0011){ref-type="ref"}, [^12^](#jmd212154-bib-0012){ref-type="ref"}, [^13^](#jmd212154-bib-0013){ref-type="ref"}, [^14^](#jmd212154-bib-0014){ref-type="ref"}, [^15^](#jmd212154-bib-0015){ref-type="ref"}

Here we report two additional cases of COG6‐CDG with the previously described ultra‐rare homozygous nonsense mutation c.511C\>T, p.(Arg171\*) in the *COG6* gene[^12^](#jmd212154-bib-0012){ref-type="ref"} presenting with prominent skin features at birth resembling restrictive dermopathy and a fatal course with respiratory insufficiency, thrombocytopenia, and hepatosplenomegaly.

2. CASE SUMMARY {#jmd212154-sec-0004}
===============

The index patient (P2, Figure [1A](#jmd212154-fig-0001){ref-type="fig"}) was the fourth child of healthy nonconsanguineous parents from Greece. The first‐born child was a healthy 9‐year‐old girl and the third child was a healthy 4‐year‐old boy at the time of diagnostic testing of the proband, the second child (P1, Figure [1A](#jmd212154-fig-0001){ref-type="fig"}) died at the age of 15 days due to respiratory insufficiency and had shown clinical signs very similar to those of the fourth child (P2). Unfortunately, no medical records of the second child (P1) were available and the parents reported that no definitive diagnosis had been achieved. According to the descriptions of the parents the female child was born prematurely, showed a very dry and tight skin, generalized joint contractures, and had to be ventilated immediately after birth. After extubation, the girl died on day 15. Pregnancy with the fourth child had been complicated around gestational week 25 by oligohydramnios, and on prenatal ultrasound moderate cardiomegaly, lung hypoplasia, intrauterine growth retardation, hyperechogenic liver and clubfoot of the fetus were observed. Prenatal FISH analysis of amniotic fluid excluded trisomy 13, 18, and 21. In gestational week 29 a normal amount of amniotic fluid for gestational age was recorded. The girl was born prematurely after cesarean section because of fetal distress at 30 + 2 gestational weeks with a birth weight of 975 g (10th percentile), birth length of 35 cm (3rd‐10th percentile) and a head circumference of 26.5 cm (10th‐25th percentile). Apgar score was 1/5/7. The child showed severe muscular hypotonia and had no spontaneous breathing and was intubated and ventilated, with postnatal adaptation complicated by respiratory insufficiency due to lung hypoplasia. She showed signs of arthrogryposis with talipes equinovarus, generalized joint contractures and thoracolumbal scoliosis. She had a small pinched nose, dysplastic ears and incomplete eye closure. The most striking feature was her very dry, tight and rigid skin with skin erosions, hyperkeratosis, scaling (Figure [1B](#jmd212154-fig-0001){ref-type="fig"}), and nearly absent eyelashes and eyebrows. A skin biopsy sample was taken at the Neonatology Unit and examined at an external laboratory showing unspecific changes typical for an immature development of the epidermis and dermis. Many of the clinical features at birth resembled restrictive dermopathy and the histology was described to be compatible with secondary changes of RD; however, no specific changes for RD were noted. Abdominal ultrasound detected hepatosplenomegaly and echocardiography demonstrated a persistent foramen ovale. Brain ultrasound was normal. Laboratory investigations revealed hyponatremia and thrombocytopenia (49 G/l). In spite of continuous ventilation the patient\'s clinical state worsened, and on the fourth day of life, she developed a global respiratory insufficiency and expired.

![A. Pedigree of the family indicating heterozygosity or homozygosity for the c.511C\>T variant in the *COG6* gene. The arrow indicates the proband. B. Photo of patient P2 revealing the skin phenotype and joint contractures. C. Electropherogram of the Sanger sequencing showing the homozygous nonsense mutation c.511C\>T, p.(Arg171\*) in the *COG6* gene in the proband confirming the NGS results; in order of the sequence: proband P2, the red bar indicates the homozygous base exchange; father and mother, respectively, blue bars indicate the heterozygous state of the sequence variant. The confirmation of the NGS results and the segregation analysis was performed by Sanger sequencing on an ABI 3500 DNA Sequencer](JMD2-55-51-g001){#jmd212154-fig-0001}

3. RESULTS {#jmd212154-sec-0006}
==========

According to the initial clinical suspicion of restrictive dermopathy Sanger sequencing of the two known causative genes *LMNA* and *ZMPSTE24* was carried out but detected no pathogenic alterations. For further analysis postmortem trio whole‐exome sequencing (Agilent SureSelect XT Human All Exon Kit V6, Agilent Technologies, Santa Clara, California) was performed and revealed the homozygous nonsense mutation c.511C\>T, p.(Arg171\*) in the *COG6* gene in the index patient (P2). Both parents were heterozygous carriers. The mutation was validated by Sanger sequencing (Figure [1C](#jmd212154-fig-0001){ref-type="fig"}). This variant was already described by Rymen et al[^12^](#jmd212154-bib-0012){ref-type="ref"} and is listed in ClinVar (NM_001145079.1(COG6): c.511C\>T, (p.Arg171\*), <https://www.ncbi.nlm.nih.gov/clinvar/variation/493007>) and HGMD (CM1512209) as pathogenic. Following standard filtering only two additional homozygous variants remained in the index patient (Supplementary [Table 1](#jmd212154-supitem-0001){ref-type="supplementary-material"}.): a homozygous missense variant of uncertain significance in the *NOXA1* gene (MIM \*611255) and a homozygous missense variant of uncertain significance in the *NOTCH1* gene (MIM \*190198). No further causative or possibly causative variants were identified in the trio analysis that would explain the striking phenotype in the index patient. Biallelic pathogenic variants in the *COG6* gene (MIM \*606977) are responsible for COG6‐CDG (MIM \#614576).

4. DISCUSSION {#jmd212154-sec-0007}
=============

We present two siblings with a lethal neonatal phenotype of COG6‐CDG whose striking skin features initially raised the suspicion of an underlying restrictive dermopathy. Since the symptoms of the disease were already present prenatally and involved multiple organ systems including severe arthrogryposis, hepatosplenomegaly, thrombocytopenia, and respiratory insufficiency and showed a rapid fatal course, the overall clinical picture pointed toward a glycosylation disorder. Dry skin, tight and rigid skin with hyperkeratosis and scaling at birth represents the clinical phenotype of heterogeneous diseases ranging from nonsyndromic genodermatosis to fatal multiorgan disorders including inborn errors of metabolism. Restrictive dermopathy manifestations include a tense, vulnerable and translucent skin with prominent vessels, superficial erosions, joint contractures, reduced motoricity, a typical facies, and respiratory insufficiency.[^1^](#jmd212154-bib-0001){ref-type="ref"} Although both of the siblings we present here showed tightly adherent skin and generalized joint contractures, they also presented with immediate respiratory insufficiency, hepatosplenomegaly, and thrombocytopenia. During the short life span of the index patient (P2) only sequencing of *ZMPSTE24* and *LMNA* known to be causative for restrictive dermopathy was performed and detected no pathogenic alterations. With the aim of providing the parents exact recurrence risks and the opportunity to obtain prenatal diagnostics in future pregnancies trio whole‐exome sequencing was performed postmortem and revealed the homozygous nonsense mutation c.511C\>T, p.(Arg171\*) in the *COG6* gene in the proband (P2, Figure [1C](#jmd212154-fig-0001){ref-type="fig"}) leading to the diagnosis of COG6‐CDG. Both parents were heterozygous carriers. No postmortem sample was available from the first deceased child (P1, Figure [1A](#jmd212154-fig-0001){ref-type="fig"}); however, the phenotypic description of the parents showed striking similarity to the manifestations of the second affected child. Unfortunately, the functional relevance of the homozygous variant could not be supported by isoelectric focusing of serum transferrin in our patients.

Although no consanguinity is known between the parents of our patients, the presence of a homozygous ultra‐rare variant hypothesizes some degree of consanguinity and increases the chances of a second unrelated genetic error that may explain the prominent skin phenotype. Following standard filtering only three homozygous variants remained in the index patient (Supplementary [Table 1](#jmd212154-supitem-0001){ref-type="supplementary-material"}): the previously described pathogenic missense variant in *COG6*, and two variants with uncertain significance: a homozygous variant in the *NOXA1* gene (MIM \*611255) that is not yet associated with a disease entity and a homozygous missense variant in the *NOTCH1* gene (MIM \*190198) causative of autosomal dominant Aortic valve disease (MIM \#109730) and Adams‐Oliver syndrome Type 5 (MIM \#616028). We do not think that the two Class 3 variants exerted a significant contribution to the skin phenotype. We were not able to identify additional variants that would have possibly contributed to the skin phenotype, nor were we able to identify any pathogenic variants in genes associated with the most closely related HPO terms of the skin phenotype seen in our patients (for the gene list see Supplementary [Table 2](#jmd212154-supitem-0002){ref-type="supplementary-material"}). The two patients reported so far with the c.511C\>T variant in *COG6* ~12~ and our patients originate from the same geographical area of South‐Eastern Europe (Bulgaria, Turkey and Greece), thus the variant could also possibly represent a local founder mutation. The gnomAD database lists eight heterozygous carriers, two from the Askhenazi Jewish, and six from the European (non‐Finnish) population. Comparative haplotype analysis of other families carrying the same mutation will be the approach to resolve this possibility.

Skin abnormalities are described in about 20% of the different CDG forms[^5^](#jmd212154-bib-0005){ref-type="ref"}, [^6^](#jmd212154-bib-0006){ref-type="ref"}, [^9^](#jmd212154-bib-0009){ref-type="ref"}, [^16^](#jmd212154-bib-0016){ref-type="ref"}, [^17^](#jmd212154-bib-0017){ref-type="ref"}, [^18^](#jmd212154-bib-0018){ref-type="ref"} and include abnormal fat distribution, lipodystrophy, cutis marmorata,[^19^](#jmd212154-bib-0019){ref-type="ref"} excessive skin wrinkling, orange peel skin,[^17^](#jmd212154-bib-0017){ref-type="ref"} ichthyosis,[^5^](#jmd212154-bib-0005){ref-type="ref"}, [^6^](#jmd212154-bib-0006){ref-type="ref"} hyperkeratosis,[^9^](#jmd212154-bib-0009){ref-type="ref"} increased skin laxity, hypo−/hyperpigmentation, tumoral calcinosis, aplasia cutis congenita,[^18^](#jmd212154-bib-0018){ref-type="ref"} and hypohidrosis/hyperthermia.[^15^](#jmd212154-bib-0015){ref-type="ref"}, [^16^](#jmd212154-bib-0016){ref-type="ref"} Ichthyosis or ichthyosiform dry skin with variable neurologic and multiorgan involvement is particularly a feature of four types of CDG caused by mutations in the genes *MPDU1*, *DOLK*, *SRD5A3*, and *PIGL*.[^16^](#jmd212154-bib-0016){ref-type="ref"}, [^20^](#jmd212154-bib-0020){ref-type="ref"} It has been proposed that a distinctive feature of COG6‐CDG compared to other CDG can be additional ectodermal signs including hypohidrosis/hyperthermia, dry, orange peel skin, hyperkeratosis, and tooth anomalies.[^11^](#jmd212154-bib-0011){ref-type="ref"}, [^12^](#jmd212154-bib-0012){ref-type="ref"}, [^15^](#jmd212154-bib-0015){ref-type="ref"} Reviewing the literature, however, abnormality of the skin is reported only in about one third of all COG‐CDG (13/48 cases) and in about one third of all COG6‐CDG (6/21) cases (References [11](#jmd212154-bib-0011){ref-type="ref"}, [12](#jmd212154-bib-0012){ref-type="ref"}, [20](#jmd212154-bib-0020){ref-type="ref"} and our patients). No case has been reported so far with the description of dry, tight and rigid skin at birth (Table [1](#jmd212154-tbl-0001){ref-type="table"}). Applying the approach of Haijes et al[^11^](#jmd212154-bib-0011){ref-type="ref"} to our patients to assess the relevance of phenotypic similarities (Supplementary [Table 2](#jmd212154-supitem-0002){ref-type="supplementary-material"}), we found evidence of similar skin phenotype terms in a few other COG‐CDG cases: "thickened skin," "epidermal thickening," and "hyperkeratosis" is mentioned in 5/21 COG6‐CDG cases while "dry skin" in 4/21 COG6‐CDG cases and in 1/3 COG8‐CDG case but "tight skin" (lack of skin elasticity) only in our two patients (2/21).[^11^](#jmd212154-bib-0011){ref-type="ref"}, [^21^](#jmd212154-bib-0021){ref-type="ref"} Due to the scarce reports of the skin phenotype in most cases phenotypic specificity was very low for most skin related HPO terms, only for hypohidrosis did it reach 0.20. The biochemical mechanisms for the skin symptoms in COG‐CDG are not known yet and there are no reports of the dermatopathological changes in the few described patients. Unfortunately, there was no precise histopathological description in our patient available either. Skin histology is presented in a neonatal case of DOLK‐CDG with severe ichthyosis at birth and showed lipid droplet accumulation in the stratum corneum and keratinocytes, suggestive of defective epidermal lipid metabolism. It was hypothesized that epidermal lipid metabolism may be dependent on normal glycosylation and could be perturbed in various CDG defects.[^22^](#jmd212154-bib-0022){ref-type="ref"} We chose the HPO term "tight skin" (lack of skin elasticity) to assess the pathophysiology in other diseases presenting with "tight skin" (gene ontology for 41 genes) in an attempt to identify additional cellular functions possibly accounting for the skin features (Supplementary [Table 2](#jmd212154-supitem-0002){ref-type="supplementary-material"}). We were not able to assess a specific pattern apart from the overrepresentation of cell signaling among those gene functions. More COG6‐CDG patients with the precise description of ectodermal features will be needed to study the underlying pathophysiology systematically.

###### 

Reported COG6‐CDG patients with skin abnormalities

                                Rymen et al (P3)[^12^](#jmd212154-bib-0012){ref-type="ref"}   Rymen et al (P4.1)[^12^](#jmd212154-bib-0012){ref-type="ref"}   Rymen et al (P4.2)[^12^](#jmd212154-bib-0012){ref-type="ref"}   Rymen et al (P6.1)[^12^](#jmd212154-bib-0012){ref-type="ref"}          Shaheen et al[^22^](#jmd212154-bib-0022){ref-type="ref"}      Our patient
  ----------------------------- ------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------------------
  *COG6* variants               c.1238_1239insA, p.(Phe414Leufs\*4) hom                       c.1646G\>T, p.(Gly594Val)/c.785A\>G, p.(Tyr262Cys)              c.1646G\>T, p.(Gly594Val)/c.785A\>G, p.(Tyr262Cys)              c.511C\>T, p.(Arg171\*)/c.1746+2G\>T                                   c.1167‐24A\>G hom                                             c.511C\>T, p.(Arg171\*) hom
  Skin                          Hyperkeratosis                                                Hyperkeratosis of palms and soles                               Dry skin                                                        Orange peel skin                                                       Palmoplantar hyperkeratosis                                   Tight, rigid, dry skin resembling restrictive dermopathy
  Hypohidrosis/hyperthermia     NA                                                            Yes                                                             Yes                                                             Yes                                                                    Yes                                                           NA
  Cause of death                Liver failure                                                 --                                                              Liver failure                                                   --                                                                     --                                                            Respiratory failure
  Facial dysmorphism            Retrognathia, broad palpebral fissures                        Wide mouth with thin lips, prominent nose, slight epicanthus    Not described                                                   Epicanthic folds, tubular nose, large mouth with gingiva hyperplasia   Flaring of the lateral eyebrows, broad nasal tip, full lips   Small nose, O‐shaped mouth
  Growth retardation            Yes                                                           No                                                              No                                                              Yes                                                                    NA                                                            Yes
  Microcephaly                  Yes                                                           Yes                                                             Yes                                                             Yes                                                                    No                                                            Yes
  Brain anomalies               Cerebral and cerebellar atrophy                               NA                                                              NA                                                              Cortical atrophy                                                       NA                                                            US normal
  Congenital heart defect       ASD, PDA                                                      NA                                                              NA                                                              VSD                                                                    NA                                                            PFO
  Pulmonary hypoplasia          No                                                            No                                                              No                                                              No                                                                     No                                                            Yes
  Gastrointestinal tract        Chronic diarrhea                                              Normal                                                          NA                                                              Chronic diarrhea                                                       NA                                                            NA
  Liver and biliary tract       Hepatosplenomegaly                                            Splenomegaly                                                    Hepatosplenomegaly, cholestasis, liver failure                  Hepatosplenomegaly, cholestasis, cirrhosis                             NA                                                            Hepatosplenomegaly
  Skeletal anomalies            Postaxial polydactyly, metopic synostosis                     No                                                              No                                                              Hypermobility of joints, scoliosis                                     NA                                                            Clubfoot, joint contractures, scoliosis
  Hematological abnormalities   Thrombocytopenia                                              Thrombocytopenia                                                NA                                                              Mild pancytopenia                                                      NA                                                            Thrombocytopenia

Abbreviations: ASD, atrial septal defect; F, female; M, male; NA, not assessed; PDA, patent ductus arteriosus; PFO, patent foramen ovale; US, ultrasound; VSD, ventricular septal defect.

Due to the limited number of COG6‐CDG patients reported to date, no clear genotype‐phenotype correlation has been established. Only the deep intronic splice site mutation (c.1167‐24A\>G) is clearly correlated with Shaheen syndrome (OMIM \#615328,[^23^](#jmd212154-bib-0023){ref-type="ref"}). The nonsense mutation *COG6*: c.511C\>T, p.(Arg171\*) detected in our patient was previously described by Rymen et al: patient P1, who was homozygous for the variant, presented with hypohidrosis and hyperthermia but no other skin abnormality, patient P6.1, who was compound heterozygous, had orange peel skin and hypohidrosis (Reference [12](#jmd212154-bib-0012){ref-type="ref"}, Table [1](#jmd212154-tbl-0001){ref-type="table"}). In contrast, the most striking feature in our patients was the dry, tight and rigid skin. Hypohidrosis and hyperthermia could not be assessed during the short life span of our patient (P2) placed into an incubator immediately after birth, nor was data available from the first affected child (P1, Figure [1A](#jmd212154-fig-0001){ref-type="fig"}). Clinical features common to all three patients confirmed to carry the c.511C\>T, p.(Arg171\*) variant were facial dysmorphism, growth retardation, microcephaly, congenital heart defect, hepatosplenomegaly, skeletal anomalies, and thrombocytopenia. Patients homozygous for the c.511C\>T variant additionally showed multiple joint manifestations (clubfoot, opposed thumbs, hip dysplasia, scoliosis). The course of the disease was similarly severe and fatal with immediate intubation and ventilation after birth and death after stopping ventilation.

In the pregnancy with our index patient (P2, Figure [1A](#jmd212154-fig-0001){ref-type="fig"}), oligohydramnios, moderate cardiomegaly, lung hypoplasia, intrauterine growth retardation, hyperechogenic liver and clubfoot of the fetus were observed around gestational week 25. However, in gestational week 29 a normal amount of amniotic fluid was recorded, so there was no evidence of a longstanding oligohydramnios. Nevertheless, a potential role of the oligohydramnios in the skin features of our patient cannot be ruled out. However, in contrast with the skin observations of Hall[^24^](#jmd212154-bib-0024){ref-type="ref"} examining the relationship of longstanding oligohydramnios to arthrogryposis and the secondary and/or tertiary effect on fetal skin, wrinkled skin was only observed on the upper arms in our patient (P2), but no extra skin or skin creases were present elsewhere. She rather presented with tight skin. We do not think, therefore, that the skin features in our patient only developed as a secondary effect of the oligohydramnios but rather believe that the rigid and tight skin may represent the severe end of the spectrum of skin manifestations that have been observed in other COG‐CDG cases so far.

The family we describe here adds to the severe neonatal presentation of COG6‐CDG with prominent skin manifestations at birth and emphasizes the importance of considering the congenital disorders of glycosylation among the possible diagnoses for congenital genodermatoses.

5. CONCLUSION {#jmd212154-sec-0008}
=============

Our case adds to the broad phenotypic spectrum of COG6‐CDG and underlines the value of trio exome sequencing in children with severe disease course and early perinatal death. Reaching a molecular genetic diagnosis in such fatal cases is, however, a requirement for targeted carrier testing in parents and prenatal or preimplantation genetic diagnosis in further pregnancies.
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